2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1811453475
Verify on CMS →

LEILA SHOBAB

Endocrinology, Diabetes & Metabolism Physician in BETHESDA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
525
Medicare Part D claims · 84 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.9921/100
▲ 13 pts above national avg 83.1 · [object Object]

What the federal data shows

LEILA SHOBAB reported a CMS MIPS final score of 95.9921/100 — above the 83.1 national average — and filed 525 Medicare Part D claims in 2023.

95.9921/100
MIPS score · +13 vs avg
525
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LEILA SHOBAB's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

96 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LEILA SHOBAB practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LEILA SHOBAB?

High performer (top quartile)

NPI registry status

Active

Issued 02/19/2019

NPI 1811453475

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

525 80% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

95.9921/100 12.8921% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Maryland

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Maryland providers

Maryland providers

Endocrinology, Diabetes & Metabolism Physician share within Maryland

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Maryland

Medicare quality performance — MIPS

LEILA SHOBAB's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
95.9921/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 95.9921/100 vs national avg 83.1

0%100%National avg83%96%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 95.9921/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LEILA SHOBAB appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider at 5514 GREENTREE RD, BETHESDA, MD, 20817, with a listed phone of (240) 848-0645. NPI 1811453475 was issued on 02/19/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHOBAB most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 525 prescription claims written by this provider, covering 84 Medicare beneficiaries and totaling roughly $289K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.9921/100 for the 2023 performance year (Quality 85.4835, Cost 74.8785), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5514 GREENTREE RD
BETHESDA, MD 20817

Provider Details

NPI 1811453475
Specialty Endocrinology, Diabetes & Metabolism Physician
Gender Female
NPI Issued 02/19/2019

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.9921
Final Score
Avg: 83.1
85.4835
Quality
74.8785
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where LEILA SHOBAB bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEDSTAR MEDICAL GROUP II LLC
WASHINGTON, DC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

LEILA SHOBAB — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 525 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

525
Total Claims
$289K
Total Drug Cost
84
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,080
Total Day Supply
32,025
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$272K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
69.9 years
Avg HCC Risk Score
1.95
Gender Split
60% female / 40% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LEILA SHOBAB prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
92
Jardiance
Empagliflozin
62
Metformin Hcl
58
Trulicity
Dulaglutide
31
Atorvastatin Calcium
25
Novolog Flexpen
Insulin Aspart
19
Ozempic
Semaglutide
19
Alendronate Sodium
18
Humalog Kwikpen U-100
Insulin Lispro
15
Victoza 3-Pak
Liraglutide
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How LEILA SHOBAB fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

LEILA SHOBAB's 525 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as SHOBAB.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LEILA SHOBAB's specialty?
LEILA SHOBAB specializes in Endocrinology, Diabetes & Metabolism Physician and practices in BETHESDA, Maryland.
How much does LEILA SHOBAB prescribe under Medicare Part D?
In 2023, LEILA SHOBAB wrote 525 Medicare Part D claims totaling $289K in drug costs for 84 beneficiaries.
What is LEILA SHOBAB's Medicare quality score?
LEILA SHOBAB has a CMS MIPS Final Score of 95.9921/100 (Quality: 85.4835, Cost: 74.8785). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LEILA SHOBAB located?
LEILA SHOBAB is located at 5514 GREENTREE RD, BETHESDA, MD, 20817. Phone: (240) 848-0645.
What is LEILA SHOBAB's NPI number?
LEILA SHOBAB's National Provider Identifier (NPI) is 1811453475, issued on 02/19/2019.
Does LEILA SHOBAB prescribe more brand-name or generic drugs?
LEILA SHOBAB's prescribing is 51% brand-name and 49% generic drugs by claim count, with $272K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does LEILA SHOBAB prescribe most often?
Based on 2023 Medicare Part D data, LEILA SHOBAB's most frequently prescribed drugs include Levothyroxine Sodium, Jardiance, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LEILA SHOBAB accept Medicare?
LEILA SHOBAB appears in CMS Medicare data with 525 Part D claims and 84 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LEILA SHOBAB's credentials?
LEILA SHOBAB's NPI is 1811453475. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology